Fox Health

Reports of heart inflammation among a small fraction of Pfizer and Moderna COVID-19 vaccine recipients, predominantly males under 30, are under review as an advisory panel to the Centers for Disease Control and Prevention is set to meet Friday.

A new treatment triggered immune cells to clear out toxic plaque buildup and slow progression of Alzheimer’s disease in monkeys, researchers claim.

New York Gov. Andrew Cuomo announced Tuesday that all remaining COVID-19 restrictions "would be relaxed as of today" after the state reached its goal of vaccinating 70% of the adult population, but mask-wearing would remain in effect for some.

The U.S. recorded a grim milestone Tuesday with over 600,000 deaths attributed to coronavirus, according to data from Johns Hopkins University. However, the news comes as weekly fatalities have declined to lows not seen since early on in the pandemic.

A new study is warning that people who wear makeup may be unknowingly absorbing potentially toxic chemicals into their bodies.

AstraZeneca’s antibody cocktail failed to prevent COVID-19 symptoms in trial participants recently exposed to the virus, the company announced Monday.

A White House official confirmed on Tuesday that 1.35 million doses of Johnson & Johnson’s COVID-19 vaccine had arrived in Mexico.

Vermont became the first state on Monday to see over 80% of eligible residents receive at least one dose of a COVID-19 vaccine.

Hawaiian health officials said Monday that a fully vaccinated resident who traveled to Nevada last month has since tested positive for the Delta coronavirus variant.

A small study offers the first hint that an extra dose of COVID-19 vaccines just might give some organ transplant recipients a needed boost in protection.

Maryland-based biotech company Novavax on Monday announced its experimental COVID-19 vaccine remained effective when coadministered with an approved flu shot.

A study out of Scotland has found the Delta COVID-19 variant carries double the risk of hospitalization compared to the Alpha strain, particularly in patients with five or more comorbidities.

The U.K. will face another four weeks of COVID-19-related restrictions, Prime Minister Boris Johnson announced Monday amid concerns of rapid spread of a highly transmissible Delta variant.

A top expert with the U.K.’s Scientific Advisory Group for Emergencies (SAGE) on Sunday warned the region is approaching a third wave of COVID-19 infections as a highly transmissible variant first detected in India continues to proliferate.

The former head of the FDA said that while the Delta variant currently accounts for about 10% of coronavirus infections in the U.S., it’s doubling at a rate of every two weeks meaning "it’s probably going to become the dominant strain."

New COVID-19 cases are declining across most of the country, even in some states with vaccine-hesitant populations.

Novavax announced on Monday that its COVID-19 vaccine was found to be over 90% effective overall, and offered 100% protection against moderate and severe disease in a Phase 3 clinical trial.

Dr. Eugene Choi, a Los Angeles-based radiologist, said in an interview published Saturday that he came down with COVID-19 despite receiving the vaccine about six months ago.

Dr. Anthony Fauci, President Biden’s chief medical adviser, spoke with a leading expert on Friday on methods to expand COVID-19 vaccination coverage among adolescents.

While Americans have shifted to heavier alcohol use during the pandemic, studies indicate a concerning pattern among women as they drank to relieve stress, boredom and the pain from social isolation.